Abstract:Scientific Committee Adriana Pedrosa Ana Paula Azevedo Ana Paula Castro Ana Paula Faria Caterina Faria Coelho Elsa Gonçalves Eulália Costa Fátima Vale Fernando Rodrigues Henrique Reguengo João Faro Viana João Mário Figueira João Tiago Guimarães Jorge Nunes de Oliveira Luísa Espinhaço Lurdes Pereira Manuela Ribeiro Maria José Teles Maria Luís Queirós Rosário Luís Rui Farinha 1 Centro Hospitalar Médio Tejo Keywords: chromatograms , hemoglobinopathies, diabetes monitoring, screening Background : Hemoglobinopathies are the most common group of genetic disorders worldwide. They mainly result from autosomal recessive transmission of mutated genes behind the synthesis of globin chains, and fall into two main groups: thalassemia syndromes, and structural haemoglobin (Hb) variants. Although some Hb variants are silent in heterozygotes, they can be severe in homozygous forms. Aim : To analyse the incidence of hemoglobinopathies in all samples studied both for guided screening and incidental finding, in the last 5 years and to show up the laboratory contribution in screening these conditions. Methods : Data collection from LIS and Hospital Health Care System in our laboratory during Jan 2018 to Feb 2023. A total of 41003 samples were included in the study, 495 with directed request and 40508 for diabetes monitoring only. Hb A 2 , Hb F and Hb variants analysis was performed by HPLC. Then, electrophoresis was performed. Hb S was confirmed by the solubility test. In order to identify rare Hb variants, some samples were sent to a reference laboratory for alternative methods and/or by molecular biology analysis. Results : After eliminating the duplicates, a total of 6144 individual samples were studied, of which 199 (3.2%) had genetic Hb disorders. From 495 requested tests by physician, 71 (14.3%) had disorders, while 128 (64.3%) were suggested by lab stuff. The main condition found in the studied population were sickle cell trait (46.2%), followed by β-thalassemia minor (26.1%), Hb Lepore (11.6%), and others. Rare cases were found with co-inheritance of heterozygous alpha thalassemia and sickle trait (0.5%), and Hb E in heterozygous condition (HBB: c.79G>A; p.Glu27Lys) and compound heterozigoty in the gene HBA del-- SEA / HBA2: c.369C>G; pHis123Gln (Hb Westmead) (0.5%). Conclusion : This study revealed that few genetic Hb disorders derived from oriented study. Our results also highlighted that clinical pathology service is essential in routine chromatograms analysis to screening hemoglobinopathies. Most, came of unintentional lab findings of carriers unaware of their status. Our results show a significantly higher prevalence of hemoglobinopathies compared to last Portuguese population data. In addition, those data fully justify an accurate analysis of all chromatograms. 1 Centro Hospitalar do Tâmega e Sousa Introduction: Congenital Leukemia (CL) is an extremely rare diagnosis, with a reported incidence of 1 per 5 million births. It is a disorder that develops in utero, with clinical manifestations after birth or shortly thereafter. Most CL are myeloid in origin, unlike pediatric leukemias, which are usually lymphoid. Case Report: A full term male newborn, adequate for gestational age, with no relevant family history, was born after an uncomplicated pregnancy apart from a prenatal diagnosis of alloimmunization by Kell antigen. Physical examination a few hours after birth was unremarkable except for the presence of widespread purple nodules on his skin. Blood test results revealed a complete blood count (CBC) with a mild non-regenerative anemia and hyperleukocytosis (106 600/μL), a positive direct antiglobulin test, and elevated AST and LDH without hyperbilirubinemia. Due to CBC abnormalities, a peripheral blood smear (PBS) was performed, which showed the presence of 71% of immature cells, with a high nucleus-cytoplasm ratio, fine chromatin, 1-2 nucleoli and some with granules on their cytoplasm. The presence of a high percentage of apparent blasts circulating in peripheral blood, with hyperleukocytosis and the widespread purple nodules on the skin, raised the suspicion of a probable CL. Given the lack of a Pediatric Haematology Department in the referring hospital, the newborn had to be transferred to another hospital for further studies and management of the disease. Discussion: CL represent about 0,8% of all childhood leukemias, and can present a diagnostic challenge due to the heterogeneity of clinical presentation. Therefore, a multidisciplinary approach and cooperation between clinicians and the laboratory are fundamental. Analysis of the PBS can be indispensable as an auxiliary diagnostic tool to -Abstract Truncated-

The Application of Clinical and Molecular Diagnostic Techniques to Identify a Rare Haemoglobin Variant

Inherited disorders of hemoglobin: A review of old and new diagnostic methods

Diagnosis and Screening of Abnormal Hemoglobins

Establishing the Approach to the Diagnosis of Hemolytic Anemia in the Genetic Era: A Case Series

Hemoglobin A2 and Heterogeneous Diagnostic Relevance Observed in Eight New Variants of the Delta Globin Gene

Genetic Modifiers of Hemoglobin Expression from a Clinical Perspective in Hemoglobinopathy Patients with Beta Thalassemia and Sickle Cell Disease

The phenotypic and molecular diversity of hemoglobinopathies in India: A review of 15 years at a referral center

15th National Congress of the Portuguese Society of Clinical Chemistry, Genetics and Laboratory Medicine

Compound Heterozygous with Hb G-Taipei and Hb Lepore-Boston-Washington: an Unexpected Finding Triggered by HbA1c Measurement

A rare hemoglobinopathy duo: Hb Adana×Hb SEA in a 1-year-old patient - a case report and a brief literature review

Leveraging Multi‐Omics Approaches and Advanced Technologies to Unravel the Molecular Complexities, Modifiers, and Precision Medicine Strategies for Hemoglobin H Disease

Characterization and Clinical Assessment of a Peculiar Case of Hemolytic Anemia

The Importance of Molecular Biological Analysis for the Laboratory Diagnostic of Homozygous Haemoglobin Malay

Detection of 13 Novel Variants and Investigation of Mutation Distribution by Next Generation Sequencing in Hemoglobinopathies: A Single Center Experience

Evolution of acquired haemoglobin H disease monitored by capillary electrophoresis: a case of a myelofibrotic patient with a novel ATRX mutation

High-Oxygen-Affinity Hemoglobins—Case Series and Review of the Literature

Evaluation of role of HPLC (Merits & Pitfalls), in the diagnosis of various hemoglobinopathies & thalassemic syndromes

Hemoglobin variant in disguise

Update in Laboratory Diagnosis of Thalassemia

Rapid Targeted Next-Generation Sequencing Platform for Molecular Screening and Clinical Genotyping in Subjects with Hemoglobinopathies

Analysis of the Haematological Phenotype and Molecular Characteristics of Rare Abnormal Haemoglobin